In this special guest feature, Inga Shugalo, a Healthcare Industry Analyst at Itransition, suggests that whether it's an application for precision medicine, decreasing the failure rates in drug trials, or lowering the cost of research and developing better medicine, big data has a bright future for the pharmaceutical industry. Itransition is a custom software development company headquartered in Denver, Colorado. Inga focuses on Healthcare IT, highlighting the industry challenges and technology solutions that tackle them. Her articles explore diagnostic potential of healthcare IoT, opportunities of precision medicine, robotics and VR in healthcare and more. When it comes to investing in big data, probably, no other industry has as much at stake as pharmaceutics.